Moreover, this speculative and investigative strategy could identify other novel molecular targets (beyond estrogen receptors, HER-2, and PIK3CA) that could better inhibit BC growth and diffusion, mainly in association with currently used drugs. This evidence concerns the gene ERBB2 and breast cancer.